You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

89Zr-girentuximab

Showing 1 - 25 of 174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • 89Zr-Girentuximab
  • (no location specified)
May 14, 2023

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting
  • Cervical Cancer
  • +13 more
  • (no location specified)
Sep 28, 2022

Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

Available
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-DFO-girentuximab
  • Los Angeles, California
    UCLA
Oct 12, 2023

Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)

Recruiting
  • Bladder Cancer
  • 89Zr-TLX250 PET/CT
  • Saint Herblain, France
    Institut de cancerologie de l'Ouest
Nov 24, 2021

Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • 89Zr-Girentuximab
  • Murdoch, Western Australia, Australia
    Fiona Stanley Hospital
Aug 22, 2021

Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)

Completed
  • Carcinoma, Renal Cell
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Yokohama City, Kanagawa, Japan
    Yokohama City University Hospital
Aug 18, 2021

Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)

Recruiting
  • Urothelial Carcinoma
  • 89Zr-Girentuximab
  • Murdoch, Western Australia, Australia
    Fiona Stanley Hospital
Sep 8, 2021

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • 89Zr-TLX250
  • 177Lu-TLX250 and Peposertib
  • North Ryde, New South Wales, Australia
  • +4 more
May 22, 2023

Triple Negative Breast Cancer Trial in Saint-Herblain (89Zr-TLX250 PET/CT)

Recruiting
  • Triple Negative Breast Cancer
  • 89Zr-TLX250 PET/CT
  • Saint-Herblain, France
    ICO René Gauducheau
Oct 18, 2021

Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 16, 2022

Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Duarte, California
  • +29 more
Aug 4, 2021

Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Multiple Myeloma
  • Plasma Cell Myeloma
  • Zirconium Zr 89-DFO-YS5
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 26, 2023

Prostate Cancer Trial in New York (89Zr- DFO-MSTP2109A, 89Zr DFO-MSTP2109A)

Active, not recruiting
  • Prostate Cancer
  • 89Zr- DFO-MSTP2109A
  • 89Zr DFO-MSTP2109A
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Cancer Trial in Wuxi (89Zr-NY009)

Recruiting
  • Cancer
  • Wuxi, China
    Affiliated Hospital of Jiangnan University
Jan 19, 2023

Multiple Myeloma Trial in Wuxi (89Zr-NY008)

Recruiting
  • Multiple Myeloma
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Dec 15, 2022

Pancreatic Cancer Trial in Grand Rapids (NMK89)

Recruiting
  • Pancreatic Cancer
  • Grand Rapids, Michigan
    BAMF Health
Nov 8, 2023

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Recruiting
  • Neurofibromatosis 2
  • Bevacizumab Zirconium Zr-89
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jan 5, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • 89Zr-atezolizumab PET/CT
  • (no location specified)
Feb 22, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)

Recruiting
  • Large B-cell Lymphoma
  • DLBCL
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Amyotrophic Lateral Sclerosis Trial (89Zr-DFO-AP-101)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Jul 26, 2023

Pancreas Cancer Trial in Stanford (89Zr-panitumumab)

Suspended
  • Pancreas Cancer
  • Stanford, California
    Stanford University
Jun 15, 2022

NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

Terminated
  • Non-Small Cell Lung Cancer
  • Heidelberg, Victoria, Australia
    Austin Health
Jan 13, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022